OMRF collaborates with GSK to develop novel treatments for severe inflammatory diseases

OKLAHOMA CITY, July 24, 2017 (GLOBE NEWSWIRE) -- The Oklahoma Medical Research Foundation (OMRF) has signed a collaboration agreement with GSK, one of the world’s leading healthcare companies, for the discovery, development and commercialization of novel therapies to prevent organ damage and death caused by conditions such as acute pancreatitis, lung injury and trauma. This … [Read more...]

SolarWinds MSP Launches MSP Manager Mobile App—Technicians Gain Essential, Immediate Access to Support Information from any Android or iOS device

DURHAM, N.C., July 24, 2017 (GLOBE NEWSWIRE) -- SolarWinds MSP, a global leader in delivering comprehensive, scalable IT service management solutions to IT solution providers and MSPs, today announced the launch of its SolarWinds® MSP Manager™ mobile app which is available on both Android® and iOS® mobile devices. The MSP Manager mobile app provides instant access to all … [Read more...]

Innocoll and Gurnet Point Announcement relating to the Scheme becoming Effective

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION FOR IMMEDIATE RELEASE 24 July 2017 RECOMMENDED OFFER FOR INNOCOLL HOLDINGS PLC BY GURNET POINT L.P. ACTING THROUGH ITS GENERAL PARTNERWAYPOINT INTERNATIONAL GP LLC … [Read more...]

Tyme Inc. to Present at Precision: Lung Cancer World R&D Summit

NEW YORK, July 24, 2017 (GLOBE NEWSWIRE) -- Tyme Inc. (OTCQB:TYMI), a clinical stage biotechnology company developing cancer therapeutics to address multiple tumor types, today announced that Dr. Giuseppe Del Priore, Chief Medical Officer, will present at the 2017 Precision: Lung Cancer World R&D Summit. “Even with recent therapeutic advances, lung cancer continues to … [Read more...]

Covisint Strongly Recommends Shareholders Vote "FOR" the Sale of Covisint to Open Text  

DETROIT, July 24, 2017 (GLOBE NEWSWIRE) -- Covisint Corporation's (Nasdaq:COVS) special shareholder meeting to vote on Covisint’s proposed acquisition by OpenText™ (NASDAQ:OTEX) (TSX:OTEX) is scheduled for tomorrow, Tuesday, July 25, 2017, at 10:00 a.m. ET.  As of the date of this press release, not all Covisint shareholders have voted.  The upcoming Special Meeting, and your … [Read more...]